ArticleScience immunology2022

The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.

Gauri Mirji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.